Skip to main content
Erschienen in: Cancer Immunology, Immunotherapy 4/2020

22.01.2020 | Original Article

The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma

verfasst von: Chi-Maw Lin, Long-Wei Lin, Ya-Wen Chen, Yi-Ling Ye

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

In oropharyngeal squamous cell carcinoma (OPSCC), the relationships between immune responses, carcinogens, and prognoses are not clarified yet. Here, we retrospectively reviewed the pathology samples of 46 OPSCC patients, and used p16 to determine their human papillomavirus (HPV) status. The Cancer Genome Atlas (TCGA) database was also analyzed for further comparison. The immunofluorescence staining of proinflammatory cytokines showed that high interferon gamma (IFNγ; T helper 1; Th1), low interleukin 4 (IL4; T helper 2; Th2), low thymic stromal lymphopoietin (TSLP; Th2), and low transforming growth factor beta (TGFβ; T regulatory; Treg) expressions were good prognostic factors for OPSCC. p16-positive OPSCC showed higher Th1, lower Th2/Treg proinflammatory cytokine expressions, and a better prognosis than p16-negative OPSCC. In smokers alone, although p16-positive OPSCC smokers showed weaker Th2/Treg predominant cytokine expressions than p16-negative OPSCC smokers, the prognoses of both groups were equally poor. As for p16-positive OPSCC patients alone, p16-positive nonsmokers showed a significantly better prognosis than p16-positive smokers, but the immune responses of both groups were all weakly Th2/Treg predominant. Overall, higher Th1 and lower Th2/Treg proinflammatory cytokine expressions are associated with a better prognosis for OPSCC. HPV may be related to increased Th1, decreased Th2/Treg responses, and a good prognosis, while smoking may be related to increased Th2/Treg, decreased Th1 responses, and a poor prognosis in OPSCC. The impact of smoking on immune deviation may be weaker than that of HPV, but the impact of smoking on prognosis may be stronger than that of HPV in OPSCC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
6.
Zurück zum Zitat Elrefaey S, Massaro MA, Chiocca S, Chiesa F, Ansarin M (2014) HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital 34:299–309PubMedPubMedCentral Elrefaey S, Massaro MA, Chiocca S, Chiesa F, Ansarin M (2014) HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital 34:299–309PubMedPubMedCentral
8.
Zurück zum Zitat Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP (2017) Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 67: 122–137. https://doi.org/10.3322/caac.21389 Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP (2017) Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 67: 122–137. https://​doi.​org/​10.​3322/​caac.​21389
13.
Zurück zum Zitat Hong CC, Yao S, McCann SE et al (2013) Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers. Breast Cancer Res Treat 139:477–488. https:doi.org/1007/s10549-013-2549-3 Hong CC, Yao S, McCann SE et al (2013) Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers. Breast Cancer Res Treat 139:477–488. https:doi.org/1007/s10549-013-2549-3
14.
Zurück zum Zitat Watanabe J, Saito H, Miyatani K, Ikeguchi M, Umekita Y (2015) TSLP expression and high serum TSLP level indicate a poor prognosis in gastric cancer patients. Yonago Acta Med 58:137–143PubMedPubMedCentral Watanabe J, Saito H, Miyatani K, Ikeguchi M, Umekita Y (2015) TSLP expression and high serum TSLP level indicate a poor prognosis in gastric cancer patients. Yonago Acta Med 58:137–143PubMedPubMedCentral
19.
Zurück zum Zitat Partlová S, Bouček J, Kloudová K et al (2015) Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma. Oncoimmunology 4:e965570CrossRefPubMedPubMedCentral Partlová S, Bouček J, Kloudová K et al (2015) Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma. Oncoimmunology 4:e965570CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Edge S, Byrd DR, Compton CC, Fritz AG, Greene F, Trotti A (eds) (2010) AJCC cancer staging handbook: from the AJCC cancer staging manual. Springer, New York Edge S, Byrd DR, Compton CC, Fritz AG, Greene F, Trotti A (eds) (2010) AJCC cancer staging handbook: from the AJCC cancer staging manual. Springer, New York
28.
Zurück zum Zitat Mann EA, Spiro JD, Chen LL, Kreutzer DL (1992) Cytokine expression by head and neck squamous cell carcinomas. Am J Surg 164:567–573CrossRefPubMed Mann EA, Spiro JD, Chen LL, Kreutzer DL (1992) Cytokine expression by head and neck squamous cell carcinomas. Am J Surg 164:567–573CrossRefPubMed
29.
Zurück zum Zitat Woods KV, El-Naggar A, Clayman GL, Grimm EA (1998) Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res 58:3132–3141PubMed Woods KV, El-Naggar A, Clayman GL, Grimm EA (1998) Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res 58:3132–3141PubMed
32.
Metadaten
Titel
The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma
verfasst von
Chi-Maw Lin
Long-Wei Lin
Ya-Wen Chen
Yi-Ling Ye
Publikationsdatum
22.01.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Cancer Immunology, Immunotherapy / Ausgabe 4/2020
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-020-02488-w

Weitere Artikel der Ausgabe 4/2020

Cancer Immunology, Immunotherapy 4/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.